Delivery Order 36F79719D0246-36C77024N0090
Award Date
9/25/24
Potential Completion Date
10/9/24
Potential Value
$654K
Funding Federal Agency
Veterans Integrated Service Network 12
Contracting Federal Agency
Veterans Integrated Service Network 15
Awardee
Merz Pharmaceuticals, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raleigh, NC 27615, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Merz Pharmaceuticals, LLC, a foreign-owned, for-profit pharmaceutical company, by the Veterans Integrated Service Network 12 (VISN 12). The contract is for the delivery of LEVODOPA 42MG INHL CAP 60, a pharmaceutical product, with a ceiling value of $143,560.80 and a period of performance through September 22, 2025. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business category. Merz Pharmaceuticals also holds a...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Merck Sharp & Dohme LLC (Merck), a prominent pharmaceutical manufacturer. The contract, which is not set aside, has a ceiling value of $10,496.92 and an ultimate completion date of August 27, 2025. The contract was awarded under Merck's existing Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs. This indicates that the contract is for the delivery of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to AbbVie US LLC, a for-profit limited liability company subsidiary of global biopharmaceutical company AbbVie Inc. The contract is for the supply of FOSCARBIDOPA 12MG/ML/FOSLEVODOPA 240MG/ML injectable solution, a medication used to treat Parkinson's disease. The contract has a ceiling value of $68,991.92 and an ultimate completion date of...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract, valued at $231,396.00, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the procurement of specialized medical treatments, such as cancer therapies and advanced pharmaceuticals, to support the VA's medical programs. The contract utilizes the...
This firm fixed-price delivery order was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to Mylan Specialty L.P., a for-profit pharmaceutical manufacturer, to provide drugs and biologicals. The contract has no set-aside designation and was issued under Mylan Specialty's existing Federal Supply Schedule contract with the Department of Veterans Affairs for pharmaceuticals and related medical supplies. The delivery order has a potential...
This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 15 (VISN 15), a civilian agency of the U.S. government, to Mercer Medical, LLC, a for-profit limited liability company, on June 9, 2016. The contract has a ceiling value of $82,225.00 and an ultimate completion date of July 8, 2016. The contract is for the provision of OM PHARMACEUTICALS and does not have a set-aside designation. No additional information about a larger contract vehicle or...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $200,714.25 and has an ultimate completion date of August 26, 2024. The contract is for the delivery of various pharmaceutical products to support the medical supply needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare...
This federal contract award, valued at $18,377.86, was issued by the U.S. Department of Veterans Affairs (VA) to Galderma Laboratories, L.P., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the procurement of 6 units of the injectable pharmaceutical product NEMOLIZUMAB CCP 30MG INJ, with a completion date of November 30, 2024. The contract is a firm fixed-price purchase order, and there were no set-aside requirements. Galderma Laboratories, L.P. has a history of...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $99,900.00, is for the delivery of Miltefosine 50mg tablets, a critical medication used to treat leishmaniasis and other drug-resistant infections. This purchase order is part of a larger $1,127,000 Blanket Purchase Agreement (BPA) held by Profounda Inc. with the VA's...
<p>This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency of the U.S. Department of Veterans Affairs, to Novartis Vaccines and Diagnostics, Inc., a foreign-owned for-profit manufacturer. The contract, valued at $135,200.00, is for pharmacy orders and does not have a set-aside designation. No further details about larger contract vehicles or subcontractors are provided.</p>